Commit To Purchase Supernus Pharmaceuticals At $23, Earn 8.1% Annualized Using Options
Investors considering a purchase of Supernus Pharmaceuticals Inc (Symbol: SUPN) stock, but tentative about paying the going market price of $29.37/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contrac
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-991180154-aad62bea33e2473a808a24eb81b8e068.jpg "How the Minimum Wage Impacts Unemployment")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1427847593-c401663a1b954137ac712a650eea3a95.jpg "Borrowing from Your Retirement Plan")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1711953018-c9f8489969fb4eb5b4108181d0d42071.jpg "Are We in a Baby Boomer Retirement Crisis?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1889646212-29894e7d25f24600ab15c966a1c78f89.jpg "The Long, Weird History of Universal Basic Income—and Why It’s Back")